Overview of Arveles 25 mg
| Property | Description |
|---|---|
| Active Ingredient | Dexketoprofen (INN) |
| Form | Film-coated tablet |
| Pharmacological Class | Nonsteroidal Anti-inflammatory Drug (NSAID) |
| General Purpose | Analgesic and Anti-inflammatory |
| Origin | Synthetic propionic acid derivative |
Arveles 25 mg is a prescription-only medicine whose active component is Dexketoprofen, structurally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This categorization places the medicine within a broad pharmacological group of synthetic chemical agents recognized for their ability to manage both pain and inflammation throughout the body. The Dexketoprofen compound is specifically the active S-enantiomer of ketoprofen, a single-ingredient formulation that targets the core mechanisms of discomfort.
The active substance is administered as Dexketoprofen trometamol, contained within a solid oral form presented as a film-coated tablet. The 25 mg strength precisely reflects the quantity of the active component available in each unit for systemic effect via the oral route of administration. The use of the trometamol salt form is clinically recognized for contributing to the medicine's rapid absorption, a differentiating characteristic often highlighted in pharmacological studies.
The general purpose of Arveles 25 mg is to provide fast-acting relief by modifying the body’s acute response to discomfort. It achieves its effect as an analgesic by inhibiting the activity of Cyclooxygenase (COX) enzymes, which are responsible for producing prostaglandins—local mediators that promote pain and swelling. Dexketoprofen is clinically recognized for its potent prostaglandin synthesis inhibitor properties. This systemic action is key to its role in generally alleviating acute pain episodes, such as those following minor surgical procedures or dental work, by reducing the chemical messengers responsible for triggering discomfort.
